Search
for
Sort by
Research 30 of 1000+
- Breast implant illness: a topic in review
- Revising the role of the androgen receptor in breast cancer
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients
- Becker's Nevus with Ipsilateral Breast Hypoplasia: Improvement with Spironolactone
- The Black identity, hair product use, and breast cancer scale
- Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Current Management and Treatment Options for Breast Pain
- Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
- Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century
- Experimental Confirmation of a Distinctive Diffraction Pattern in Hair From Women With Breast Cancer
- Tamoxifen-Induced Female Androgenetic Alopecia in a Patient with Breast Cancer
- Breast cancer resistance protein identifies clonogenic keratinocytes in human interfollicular epidermis
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Characterization of a Test for Invasive Breast Cancer Using X-ray Diffraction of Hair—Results of a Clinical Trial
- Breast Implant-Associated Immunological Disorders
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis
- Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
- Survey on adverse events associated with drug therapy for breast cancer patients
- Identification of Breast Cancer-Associated Lipids in Scalp Hair
- Breast Cancer: The Psychological Impact of Diagnosis, Treatment, and Remission
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial
- Breast Cancer-Related Neoplastic Alopecia: A Case Report and Review of the Literature
- Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)